Canino, Fabio
 Distribuzione geografica
Continente #
EU - Europa 333
NA - Nord America 270
AS - Asia 105
AF - Africa 2
SA - Sud America 2
Totale 712
Nazione #
US - Stati Uniti d'America 265
IT - Italia 133
IE - Irlanda 55
GB - Regno Unito 48
CN - Cina 35
HK - Hong Kong 28
DE - Germania 27
SE - Svezia 25
SG - Singapore 21
FI - Finlandia 11
ID - Indonesia 10
LT - Lituania 9
CZ - Repubblica Ceca 6
FR - Francia 6
TR - Turchia 4
BG - Bulgaria 3
CR - Costa Rica 3
CA - Canada 2
IL - Israele 2
NG - Nigeria 2
NL - Olanda 2
PL - Polonia 2
TW - Taiwan 2
AL - Albania 1
AR - Argentina 1
BE - Belgio 1
BR - Brasile 1
DK - Danimarca 1
ES - Italia 1
IN - India 1
JP - Giappone 1
NO - Norvegia 1
RU - Federazione Russa 1
VN - Vietnam 1
Totale 712
Città #
Dublin 55
Chandler 51
Ashburn 50
Bologna 34
Enfield 32
Hong Kong 28
Nyköping 25
Fairfield 24
New York 23
Singapore 14
Milan 12
Helsinki 10
Jakarta 10
San Diego 10
Beijing 9
Seattle 9
Caprarola 8
Houston 7
Phoenix 7
Reggio Emilia 7
Shanghai 7
Brno 6
Cardiff 6
Guangzhou 6
Bremen 5
London 5
Modena 5
Sassuolo 5
Savona 5
Frankfurt am Main 4
Lüleburgaz 4
Princeton 4
Wilmington 4
Woodbridge 4
Ann Arbor 3
Los Angeles 3
Munich 3
Parma 3
San José 3
Sofia 3
Acton 2
Arcola 2
Assago 2
Brooklyn 2
Cambridge 2
Casalgrande 2
Dallas 2
Florence 2
Frattamaggiore 2
Lagos 2
Naples 2
Noicattaro 2
Norwalk 2
Padova 2
Palermo 2
Rimini 2
Sant'Egidio alla Vibrata 2
Taipei 2
Toronto 2
Amsterdam 1
Atlanta 1
Bagnacavallo 1
Bengaluru 1
Brussels 1
Edinburgh 1
Falkenstein 1
Fiorenzuola D'arda 1
Groningen 1
Hangzhou 1
Hanoi 1
Jerusalem 1
Jiaxing 1
Lappeenranta 1
Madrid 1
Manhattan 1
Manoppello 1
Nagold 1
New Orleans 1
Oslo 1
Paris 1
Pisa 1
Rome 1
Salsomaggiore Terme 1
San Jose 1
Sant'agata Sul Santerno 1
St Louis 1
Tel Aviv 1
Tirana 1
Vinhedo 1
Totale 581
Nome #
The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center 106
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 104
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis 100
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges 91
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis. 66
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 48
Cemiplimab- and nivolumab-induced myasthenia gravis: two clinical cases 47
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review. 45
Adding weekly carboplatin to sequential anthracycline and paclitaxel-based chemotherapy as neoadjuvant treatment for triple negative breast cancer (TNBC) patients: a propensity scorematched study 43
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 24
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation (British Journal of Cancer, (2023), 128, 2, (266-274), 10.1038/s41416-022-02050-8) 19
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation 16
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 12
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis 6
Totale 727
Categoria #
all - tutte 5.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.663


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022118 0 34 2 1 11 1 6 15 9 2 19 18
2022/2023286 15 25 10 17 20 18 6 12 68 2 83 10
2023/2024298 22 14 27 31 22 31 41 20 16 7 34 33
2024/202525 22 3 0 0 0 0 0 0 0 0 0 0
Totale 727